BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27235536)

  • 21. Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.
    Hu ZI; Miettinen M; Quezado M; Lebensohn AP; Aldape K; Agra M; Wagner C; Mallory Y; Hassan R; Ghafoor A
    J Thorac Oncol; 2022 Mar; 17(3):461-466. PubMed ID: 34628055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations.
    Wiesner T; Fried I; Ulz P; Stacher E; Popper H; Murali R; Kutzner H; Lax S; Smolle-Jüttner F; Geigl JB; Speicher MR
    J Clin Oncol; 2012 Nov; 30(32):e337-40. PubMed ID: 23032617
    [No Abstract]   [Full Text] [Related]  

  • 23. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
    Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC
    Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
    Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
    JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
    Carbone M; Pass HI; Ak G; Alexander HR; Baas P; Baumann F; Blakely AM; Bueno R; Bzura A; Cardillo G; Churpek JE; Dianzani I; De Rienzo A; Emi M; Emri S; Felley-Bosco E; Fennell DA; Flores RM; Grosso F; Hayward NK; Hesdorffer M; Hoang CD; Johansson PA; Kindler HL; Kittaneh M; Krausz T; Mansfield A; Metintas M; Minaai M; Mutti L; Nielsen M; O'Byrne K; Opitz I; Pastorino S; Pentimalli F; de Perrot M; Pritchard A; Ripley RT; Robinson B; Rusch V; Taioli E; Takinishi Y; Tanji M; Tsao AS; Tuncer AM; Walpole S; Wolf A; Yang H; Yoshikawa Y; Zolondick A; Schrump DS; Hassan R
    J Thorac Oncol; 2022 Jul; 17(7):873-889. PubMed ID: 35462085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.
    Cheung M; Talarchek J; Schindeler K; Saraiva E; Penney LS; Ludman M; Testa JR
    Cancer Genet; 2013 May; 206(5):206-10. PubMed ID: 23849051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
    Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
    Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s.
    Carbone M; Flores EG; Emi M; Johnson TA; Tsunoda T; Behner D; Hoffman H; Hesdorffer M; Nasu M; Napolitano A; Powers A; Minaai M; Baumann F; Bryant-Greenwood P; Lauk O; Kirschner MB; Weder W; Opitz I; Pass HI; Gaudino G; Pastorino S; Yang H
    PLoS Genet; 2015 Dec; 11(12):e1005633. PubMed ID: 26683624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BAP1 and cancer.
    Carbone M; Yang H; Pass HI; Krausz T; Testa JR; Gaudino G
    Nat Rev Cancer; 2013 Mar; 13(3):153-9. PubMed ID: 23550303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BAP1-inactivated melanocytic tumor with preserved BAP1 expression? Morphology to the rescue!
    Duncan LM; Tetzlaff MT
    J Cutan Pathol; 2020 May; 47(5):459-461. PubMed ID: 32096236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
    Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH
    Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
    Pilarski R; Cebulla CM; Massengill JB; Rai K; Rich T; Strong L; McGillivray B; Asrat MJ; Davidorf FH; Abdel-Rahman MH
    Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature.
    Donati M; Šteiner P; Kazakov DV
    Am J Dermatopathol; 2023 Feb; 45(2):117-122. PubMed ID: 36669076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer.
    McDonnell KJ; Gallanis GT; Heller KA; Melas M; Idos GE; Culver JO; Martin SE; Peng DH; Gruber SB
    Cancer Genet; 2016 Mar; 209(3):75-81. PubMed ID: 26774355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline BAP1 mutations predispose also to multiple basal cell carcinomas.
    de la Fouchardière A; Cabaret O; Savin L; Combemale P; Schvartz H; Penet C; Bonadona V; Soufir N; Bressac-de Paillerets B
    Clin Genet; 2015 Sep; 88(3):273-7. PubMed ID: 25080371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
    Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H
    PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction.
    Cheung M; Kadariya Y; Talarchek J; Pei J; Ohar JA; Kayaleh OR; Testa JR
    Cancer Lett; 2015 Dec; 369(2):261-5. PubMed ID: 26409435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
    Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM
    BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malignant mesothelioma and constitutional BAP1 gene mutations].
    Neviere Z; Berthet P; Polycarpe F; Dubos-Arvis C; Dô P; Gervais R
    Rev Mal Respir; 2019 Feb; 36(2):241-248. PubMed ID: 30686559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.
    Ribeiro C; Campelos S; Moura CS; Machado JC; Justino A; Parente B
    Ann Oncol; 2013 Aug; 24(8):2147-50. PubMed ID: 23585512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.